177 related articles for article (PubMed ID: 30806920)
1. Correlation between apparent diffusion coefficient of magnetic resonance imaging and tumor-infiltrating lymphocytes in breast cancer.
Fogante M; Tagliati C; De Lisa M; Berardi R; Giuseppetti GM; Giovagnoni A
Radiol Med; 2019 Jul; 124(7):581-587. PubMed ID: 30806920
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
[TBL] [Abstract][Full Text] [Related]
3. Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index.
Mori N; Ota H; Mugikura S; Takasawa C; Ishida T; Watanabe G; Tada H; Watanabe M; Takase K; Takahashi S
Radiology; 2015 Jan; 274(1):66-73. PubMed ID: 25203132
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of imaging findings in predicting tumor-infiltrating lymphocytes in patients with breast cancer.
Çelebi F; Agacayak F; Ozturk A; Ilgun S; Ucuncu M; Iyigun ZE; Ordu Ç; Pilanci KN; Alco G; Gultekin S; Cindil E; Soybir G; Aktepe F; Özmen V
Eur Radiol; 2020 Apr; 30(4):2049-2057. PubMed ID: 31822972
[TBL] [Abstract][Full Text] [Related]
5. HER2-Positive Breast Cancer: Association of MRI and Clinicopathologic Features With Tumor-Infiltrating Lymphocytes.
Lee HJ; Lee JE; Jeong WG; Ki SY; Park MH; Lee JS; Nah YK; Lim HS
AJR Am J Roentgenol; 2022 Feb; 218(2):258-269. PubMed ID: 34431365
[No Abstract] [Full Text] [Related]
6. Can diffusion-weighted imaging predict tumor grade and expression of Ki-67 in breast cancer? A multicenter analysis.
Surov A; Clauser P; Chang YW; Li L; Martincich L; Partridge SC; Kim JY; Meyer HJ; Wienke A
Breast Cancer Res; 2018 Jun; 20(1):58. PubMed ID: 29921323
[TBL] [Abstract][Full Text] [Related]
7. Comparison of tumor-infiltrating lymphocytes of breast cancer in core needle biopsies and resected specimens: a retrospective analysis.
Cha YJ; Ahn SG; Bae SJ; Yoon CI; Seo J; Jung WH; Son EJ; Jeong J
Breast Cancer Res Treat; 2018 Sep; 171(2):295-302. PubMed ID: 29869774
[TBL] [Abstract][Full Text] [Related]
8. Correlation between
Murakami W; Tozaki M; Sasaki M; Hida AI; Ohi Y; Kubota K; Sagara Y
Eur J Radiol; 2020 Feb; 123():108773. PubMed ID: 31918248
[TBL] [Abstract][Full Text] [Related]
9. Correlation Between MRI and the Level of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer.
Ku YJ; Kim HH; Cha JH; Shin HJ; Baek SH; Lee HJ; Gong G
AJR Am J Roentgenol; 2016 Nov; 207(5):1146-1151. PubMed ID: 27556407
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging and molecular features associated with tumor-infiltrating lymphocytes in breast cancer.
Wu J; Li X; Teng X; Rubin DL; Napel S; Daniel BL; Li R
Breast Cancer Res; 2018 Sep; 20(1):101. PubMed ID: 30176944
[TBL] [Abstract][Full Text] [Related]
11. Radiological Features for Predicting the Status of CD8-Positive Lymphocytes in HER2 Positive Breast Cancer.
Fan Y; Li X; Zhong P; Guo H; Han D; Tian W; Fang J
Balkan Med J; 2024 May; 41(3):213-221. PubMed ID: 38700366
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer.
Zhou G; Chen X; Zhang J; Zhu J; Zong G; Wang Z
Eur J Radiol; 2014 Nov; 83(11):2013-8. PubMed ID: 25213829
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
Imamura T; Isomoto I; Sueyoshi E; Yano H; Uga T; Abe K; Hayashi T; Honda S; Yamaguchi T; Uetani M
Magn Reson Med Sci; 2010; 9(4):217-25. PubMed ID: 21187691
[TBL] [Abstract][Full Text] [Related]
14. Whole-Lesion Histogram Analysis of the Apparent Diffusion Coefficient as a Quantitative Imaging Biomarker for Assessing the Level of Tumor-Infiltrating Lymphocytes: Value in Molecular Subtypes of Breast Cancer.
Tang WJ; Jin Z; Zhang YL; Liang YS; Cheng ZX; Chen LX; Liang YY; Wei XH; Kong QC; Guo Y; Jiang XQ
Front Oncol; 2020; 10():611571. PubMed ID: 33489920
[TBL] [Abstract][Full Text] [Related]
15. Tumor apparent diffusion coefficient as an imaging biomarker to predict tumor aggressiveness in patients with estrogen-receptor-positive breast cancer.
Shin HJ; Kim SH; Lee HJ; Gong G; Baek S; Chae EY; Choi WJ; Cha JH; Kim HH
NMR Biomed; 2016 Aug; 29(8):1070-8. PubMed ID: 27332719
[TBL] [Abstract][Full Text] [Related]
16. A Simplified Approach to Measure the Effect of the Microvasculature in Diffusion-weighted MR Imaging Applied to Breast Tumors: Preliminary Results.
Teruel JR; Goa PE; Sjøbakk TE; Østlie A; Fjøsne HE; Bathen TF
Radiology; 2016 Nov; 281(2):373-381. PubMed ID: 27128662
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted imaging: Effects of intravascular contrast agents on apparent diffusion coefficient measures of breast malignancies at 3 Tesla.
Nguyen VT; Rahbar H; Olson ML; Liu CL; Lehman CD; Partridge SC
J Magn Reson Imaging; 2015 Sep; 42(3):788-800. PubMed ID: 25611726
[TBL] [Abstract][Full Text] [Related]
18. Apparent Diffusion Coefficient to Subdivide Breast Imaging Reporting and Data System Magnetic Resonance Imaging (BI-RADS-MRI) Category 4 Lesions.
Liu D; Ba Z; Ni X; Wang L; Yu D; Ma X
Med Sci Monit; 2018 Apr; 24():2180-2188. PubMed ID: 29644993
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Apparent Diffusion Coefficient to Predict Grade, Microinvasion, and Invasion in Ductal Carcinoma In Situ of the Breast.
Hussein H; Chung C; Moshonov H; Miller N; Kulkarni SR; Scaranelo AM
Acad Radiol; 2015 Dec; 22(12):1483-8. PubMed ID: 26391856
[TBL] [Abstract][Full Text] [Related]
20. Can Diffusion-Weighted Imaging and Related Apparent Diffusion Coefficient be a Prognostic Value in Women With Breast Cancer?
Rabasco P; Caivano R; Simeon V; Dinardo G; Lotumolo A; Gioioso M; Villonio A; Iannelli G; D'Antuono F; Zandolino A; Macarini L; Guglielmi G; Cammarota A
Cancer Invest; 2017 Feb; 35(2):92-99. PubMed ID: 28107084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
